Athens Medical Centre (FRA:ACS) Cash Flow for Dividends: €0.0 Mil (TTM As of Dec. 2025)


FRA:ACS Athens Medical Centre SA FRA:ACS
67 GF Score
Price €1.83
GF Value €1.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Cash Flow for Dividends?

Athens Medical Centre FRA:ACS +15.46% 67 Cash Flow for Dividends is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:ACS with a GF Score™ of 67/100 and a GF Value™ of €1.72 (Fairly Valued). The stock has 8 warning signs investors should review.

Athens Medical Centre's cash flow for dividends for the six months ended in Dec. 2025 was €0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Athens Medical Centre's annual payment of dividends increased from Dec. 2023 (€-0.1 Mil) to Dec. 2024 (€-1.7 Mil) but then declined from Dec. 2024 (€-1.7 Mil) to Dec. 2025 (€0.0 Mil).

Athens Medical Centre Cash Flow for Dividends Related Terms

Athens Medical Centre Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre Cash Flow for Dividends Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 0.00 -0.06 -1.73 0.00

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:ACS
67GF Score
Athens Medical Centre SA FRA:ACS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0.0 Mil mean?
Athens Medical Centre (FRA:ACS) has a Cash Flow for Dividends of €0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Athens Medical Centre and its competitors.
Is Athens Medical Centre's Cash Flow for Dividends too high?
Athens Medical Centre's current Cash Flow for Dividends is €0.0 Mil. Overall, Athens Medical Centre has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Cash Flow for Dividends compare to HCA and THC?
Athens Medical Centre's Cash Flow for Dividends of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Athens Medical Centre and its competitors. Athens Medical Centre's current Cash Flow for Dividends is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Fairly Valued. The stock's GF Value™ is €1.72, compared to a current price of €1.83 — trading 6.4% above its estimated fair value. The current Cash Flow for Dividends is €0.0 Mil. Athens Medical Centre's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current Cash Flow for Dividends is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be overvalued. The current stock price of €1.83 is trading 6.4% above its estimated GF Value™ of €1.72. GuruFocus considers Athens Medical Centre to be Fairly Valued.

Key valuation signals for FRA:ACS:

  • Cash Flow for Dividends: €0.0 Mil
  • GF Value™: €1.72 vs. price of €1.83 (6.4% above fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Other Exchanges IATR:Greece
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
67GF Score

Get the complete analysis for FRA:ACS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.83
Price
€1.72
GF Value